| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/29/2004 | US20040019052 5-(2,3-Difluorophenyl)-1H-pyrazolo(3,4-c)pyridazin-3-ylamine, e.g.; an enzyme inhibitor of GSK-3, a serine/threonine protein kinase; neuroprotectants in treatment of acute stroke, neurotraumatic injuries and diabetic conditions |
| 01/29/2004 | US20040019049 Substituted quinazolinone compounds |
| 01/29/2004 | US20040019046 Phenylacetamido-pyrazole derivatives and their use as antitumor agents |
| 01/29/2004 | US20040019045 Pyrazole compounds as anti-inflammatory and analgesic agents |
| 01/29/2004 | US20040019044 Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals |
| 01/29/2004 | US20040019040 1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents |
| 01/29/2004 | US20040019038 Compounds useful as anti-inflammatory agents |
| 01/29/2004 | US20040019028 Administering to a patient with mild cognitive impairment, a specific glucocorticoid receptor antagonist such as mifepristone to improve performance on a paragraph recall test |
| 01/29/2004 | US20040018995 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; antidiabetic agents |
| 01/29/2004 | US20040018981 Glucagon-like peptide-1 (glp-1) receptor agonist |
| 01/29/2004 | US20040018972 Autoimmune diseases; antiallergens; rheumatic diseases; antiinflammatory agents |
| 01/29/2004 | US20040018956 Aporphine esters and their use in therapy |
| 01/29/2004 | US20040018558 Method for identifying modulators of G protein coupled receptor signaling |
| 01/29/2004 | US20040018540 Evaluation method of interferon beta treatment against multiple sclerosis |
| 01/29/2004 | US20040018508 Surrogate antibodies and methods of preparation and use thereof |
| 01/29/2004 | US20040018257 In particular of avocado, soya bean and/or lupin oils, for preparation of a medicament intended to stimulate expression of TGF-62 or expression of the plasminogen activator inhibitor PAI-1 |
| 01/29/2004 | US20040018251 Petasite extract is recovered from plant of the genus Petasites; effective in treating gastrointestinal diseases, asthmas, pollinosis, dysmenorrhea, eczemas, migraines, psoriasis and high blood pressure |
| 01/29/2004 | US20040018214 Treating a non-spasm caused pain with botulinum toxin |
| 01/29/2004 | US20040018213 Treating a non-spasm caused pain with botulinum toxin |
| 01/29/2004 | US20040018212 Treating a non-spasm caused pain with botulinum toxin |
| 01/29/2004 | DE10233048A1 Verwendung von 1-Phenyl-3dimethylamino-propanverbindungen zur Therapie von depressiven Symptomatiken Use of 1-phenyl-3dimethylamino-propane compounds for the therapy of depressive symptomatology |
| 01/29/2004 | DE10230605A1 Substituierte Imidazotriazine Substituted imidazotriazines |
| 01/29/2004 | DE10230604A1 Heterocyclisch substituierte Imidazotriazine Heterocyclic substituted imidazotriazines |
| 01/29/2004 | DE10229778A1 Neue Verwendung von Imidazotriazinonen New use of imidazotriazinones |
| 01/29/2004 | DE10229180A1 Verwendung von Vasopeptidase-Inhibitoren bei der Behandlung von metabolischen Erkrankungen, Nephropathie und mit AGE assoziierten Erkrankungen Use of vasopeptidase inhibitors for the treatment of metabolic disorders, nephropathy, and diseases associated with AGE |
| 01/29/2004 | DE10224108A1 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol enthaltendes Arzneimiitel mit verzögerter Wirkstofffreisetzung 1-dimethylamino-3- (3-methoxy-phenyl) -2-methyl-pentan-3-ol-containing sustained release Arzneimiitel |
| 01/29/2004 | CA2493876A1 Tetrahydropyran derivatives and their use as therapeutic agents |
| 01/29/2004 | CA2493774A1 2,4-dihydroxybenzoic acid derivatives |
| 01/29/2004 | CA2493721A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 01/29/2004 | CA2493234A1 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
| 01/29/2004 | CA2492941A1 Remedy |
| 01/29/2004 | CA2492922A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 01/29/2004 | CA2492911A1 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
| 01/29/2004 | CA2492907A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 01/29/2004 | CA2492847A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 01/29/2004 | CA2492806A1 Targeted agents for nerve regeneration |
| 01/29/2004 | CA2492726A1 4-amino-substituted pyrimidine derivatives |
| 01/29/2004 | CA2492665A1 Azaindole kinase inhibitors |
| 01/29/2004 | CA2492651A1 Piperidine derivatives and their use as selective inhibitors of mip-1alpha binding to its receptor ccr1 |
| 01/29/2004 | CA2492498A1 Flea and tick octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 01/29/2004 | CA2492331A1 Use of convertase inhibitors in the treatment of fibrosis and scarring |
| 01/29/2004 | CA2492224A1 Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutics |
| 01/29/2004 | CA2492110A1 Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor |
| 01/29/2004 | CA2491251A1 1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 01/29/2004 | CA2491248A1 1-heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 01/29/2004 | CA2489982A1 Preparation of microbial oil containing polyunsaturated fatty acids |
| 01/29/2004 | CA2466288A1 Methods of treating conditions associated with an edg-1 receptor |
| 01/28/2004 | EP1384471A1 Osmotic extented-release dosage form |
| 01/28/2004 | EP1383927A2 New polynucleotides and polypeptides of the erythropoietin gene |
| 01/28/2004 | EP1383895A2 Polynucleotides and polypeptides of the ifnalpha-5 gene |
| 01/28/2004 | EP1383892A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/28/2004 | EP1383869A1 Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom |
| 01/28/2004 | EP1383868A2 A method for the preparation of immunologically inert amniotic membranes |
| 01/28/2004 | EP1383798A2 Transporters and ion channels |
| 01/28/2004 | EP1383789A2 Proteins associated with cell growth, differentiation, and death |
| 01/28/2004 | EP1383787A2 Sapogenin derivatives, their synthesis and use |
| 01/28/2004 | EP1383778A2 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 01/28/2004 | EP1383774A2 Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 01/28/2004 | EP1383768A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 01/28/2004 | EP1383767A1 Trifluoromethylpurines as phosphodiesterase 4 inhibitors |
| 01/28/2004 | EP1383762A1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 01/28/2004 | EP1383761A1 Phenyl- and pyridyl-piperidines with tnf activity |
| 01/28/2004 | EP1383752A2 Deuterated 3-piperidinopropiophenone and medicaments containing said compounds |
| 01/28/2004 | EP1383750A2 Urea derivatives as integrin alpha 4 antagonists |
| 01/28/2004 | EP1383748A2 Novel compounds and compositions as cathepsin inhibitors |
| 01/28/2004 | EP1383747A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 01/28/2004 | EP1383746A2 New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 01/28/2004 | EP1383744A1 Novel piperidine derivatives as modulators of chemokine receptor |
| 01/28/2004 | EP1383743A2 Dual inhibitors of pde 7 and pde 4 |
| 01/28/2004 | EP1383742A1 Synthesis and methods of use of tetrahydroindolone analogues and derivatives |
| 01/28/2004 | EP1383740A2 Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors |
| 01/28/2004 | EP1383733A2 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 01/28/2004 | EP1383730A2 Anticholinergic compounds and methods of use |
| 01/28/2004 | EP1383579A2 Composition, containing carnitine and huperzin for the prevention or treatment of learning disorders in children suffering from attention deficit/hyperactive disorder |
| 01/28/2004 | EP1383544A1 Anti-cd19 immunotoxins |
| 01/28/2004 | EP1383530A2 Laminin 5, 13 and 14 and uses thereof |
| 01/28/2004 | EP1383527A1 Methods and compositions for treating oral and esophageal lesions |
| 01/28/2004 | EP1383507A1 Utilization of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances |
| 01/28/2004 | EP1383506A2 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7 |
| 01/28/2004 | EP1383505A2 Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease |
| 01/28/2004 | EP1383503A2 Use of desoxypeganine for treating central nervous system symptoms resulting from intoxications by psychotrops |
| 01/28/2004 | EP1383501A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 01/28/2004 | EP1383498A1 Crf receptor antagonists |
| 01/28/2004 | EP1383497A2 Carbonic anhydrase activators for enhancing learning and memory |
| 01/28/2004 | EP1383489A1 Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 01/28/2004 | EP1383487A1 Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain |
| 01/28/2004 | EP1383481A1 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 01/28/2004 | EP1383465A2 Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning |
| 01/28/2004 | EP1383463A2 Pharmaceutically active compounds and methods of use |
| 01/28/2004 | EP1383460A2 Crf 2? ligands in combination therapy |
| 01/28/2004 | EP1383445A1 Formulations containing propofol and a sulfoalkyl ether cyclodextrin |
| 01/28/2004 | EP1299378A4 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/28/2004 | EP1218382B1 Bicyclic imidazo-3-yl-amine derivatives |
| 01/28/2004 | EP1183237B1 Novel antioxidants, preparation methods and uses |
| 01/28/2004 | EP1061944B1 Therapeutic chemokine receptor antagonists |
| 01/28/2004 | EP0914345B1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2) |
| 01/28/2004 | EP0708829B1 A pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms |
| 01/28/2004 | CN1471583A Packaging of positive-strand RNA virus replicon particles |
| 01/28/2004 | CN1471536A Chemokine receptor antagonsis and method of use thereof |
| 01/28/2004 | CN1471534A 桥(连)哌嗪衍生物 Bridge (even) piperazine derivatives |